194 related articles for article (PubMed ID: 3081038)
21. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
[TBL] [Abstract][Full Text] [Related]
22. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator.
Collard MW; Sylvester SR; Tsuruta JK; Griswold MD
Biochemistry; 1988 Jun; 27(12):4557-64. PubMed ID: 3048385
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.
Tamaru T; Fujibayashi S; Brown WR; Wenger DA
Histochemistry; 1986; 86(2):195-200. PubMed ID: 3028990
[TBL] [Abstract][Full Text] [Related]
24. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
25. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
Fujibayashi S; Wenger DA
Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
[TBL] [Abstract][Full Text] [Related]
26. Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.
Mancini GM; Hoogeveen AT; Galjaard H; Mansson JE; Svennerholm L
Hum Genet; 1986 May; 73(1):35-8. PubMed ID: 3086209
[TBL] [Abstract][Full Text] [Related]
27. Molecular forms of GM2-activator protein. A study on its biosynthesis in human skin fibroblasts.
Burg J; Banerjee A; Sandhoff K
Biol Chem Hoppe Seyler; 1985 Sep; 366(9):887-91. PubMed ID: 3935131
[TBL] [Abstract][Full Text] [Related]
28. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
Inui K; Wenger DA
Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
[No Abstract] [Full Text] [Related]
29. GM1-gangliosidosis: abnormalities in biosynthesis and early processing of beta-galactosidase in fibroblasts.
Nanba E; Tsuji A; Omura K; Suzuki Y
Biochem Biophys Res Commun; 1988 Apr; 152(2):794-800. PubMed ID: 3130055
[TBL] [Abstract][Full Text] [Related]
30. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.
Midorikawa M; Inui K; Okada S; Yabuuchi H; Ogura K; Handa S
J Inherit Metab Dis; 1991; 14(5):721-9. PubMed ID: 1779618
[TBL] [Abstract][Full Text] [Related]
31. Processing of human beta-galactosidase in GM1-gangliosidosis and Morquio B syndrome.
Hoogeveen AT; Graham-Kawashima H; d'Azzo A; Galjaard H
J Biol Chem; 1984 Feb; 259(3):1974-7. PubMed ID: 6420416
[TBL] [Abstract][Full Text] [Related]
32. Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency.
Zhang XL; Rafi MA; DeGala G; Wenger DA
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1426-30. PubMed ID: 1689485
[TBL] [Abstract][Full Text] [Related]
33. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids.
Fujita N; Suzuki K; Vanier MT; Popko B; Maeda N; Klein A; Henseler M; Sandhoff K; Nakayasu H; Suzuki K
Hum Mol Genet; 1996 Jun; 5(6):711-25. PubMed ID: 8776585
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and processing of lysosomal alpha-fucosidase in cultured human fibroblasts.
Johnson KF; Hancock LW; Dawson G
Biochim Biophys Acta; 1991 Jan; 1073(1):120-8. PubMed ID: 1899340
[TBL] [Abstract][Full Text] [Related]
35. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.
Paton BC; Schmid B; Kustermann-Kuhn B; Poulos A; Harzer K
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):481-8. PubMed ID: 1637339
[TBL] [Abstract][Full Text] [Related]
36. Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis.
Okamura-Oho Y; Zhang S; Hilson W; Hinek A; Callahan JW
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):787-94. PubMed ID: 8611156
[TBL] [Abstract][Full Text] [Related]
37. Biosynthesis and processing of the type II insulin-like growth factor receptor in H-35 hepatoma cells.
MacDonald RG; Czech MP
J Biol Chem; 1985 Sep; 260(20):11357-65. PubMed ID: 2993308
[TBL] [Abstract][Full Text] [Related]
38. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K
Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
[TBL] [Abstract][Full Text] [Related]
39. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
Suzuki Y; Nakamura N; Fukuoka K
Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
[TBL] [Abstract][Full Text] [Related]
40. GM1-gangliosidosis. Defective recognition site on beta-galactosidase precursor.
Hoogeveen AT; Reuser AJ; Kroos M; Galjaard H
J Biol Chem; 1986 May; 261(13):5702-4. PubMed ID: 3084469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
